KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) EBITDA (2016 - 2025)

Historic EBITDA for Labcorp Holdings (LH) over the last 17 years, with Q3 2025 value amounting to $396.6 million.

  • Labcorp Holdings' EBITDA rose 5608.03% to $396.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 7843.19%. This contributed to the annual value of $1.1 billion for FY2024, which is 4976.57% up from last year.
  • As of Q3 2025, Labcorp Holdings' EBITDA stood at $396.6 million, which was up 5608.03% from $394.5 million recorded in Q2 2025.
  • In the past 5 years, Labcorp Holdings' EBITDA ranged from a high of $1.1 billion in Q1 2021 and a low of -$122.8 million during Q4 2023
  • For the 5-year period, Labcorp Holdings' EBITDA averaged around $394.6 million, with its median value being $329.8 million (2023).
  • Its EBITDA has fluctuated over the past 5 years, first surged by 64927.31% in 2021, then tumbled by 53087.72% in 2023.
  • Quarter analysis of 5 years shows Labcorp Holdings' EBITDA stood at $519.7 million in 2021, then tumbled by 94.52% to $28.5 million in 2022, then plummeted by 530.88% to -$122.8 million in 2023, then soared by 276.3% to $216.5 million in 2024, then skyrocketed by 83.19% to $396.6 million in 2025.
  • Its last three reported values are $396.6 million in Q3 2025, $394.5 million for Q2 2025, and $326.0 million during Q1 2025.